Beem Biologics, Inc. is a pioneering company in the field of agricultural biological chemicals, striving to revolutionize crop cultivation with their innovative solutions. Established in 2015, the company is committed to developing sustainable and high-yield agricultural products. Their flagship product, ISOPLEX, has already gained recognition and has been exclusively licensed to Arysta LifeScience, a major player in the $275 billion agricultural chemical industry. This significant milestone, marked by a $494.19K Seed Round investment on 15 July 2015, serves as a testament to the company's potential and the confidence of its investors. Beem Biologics' dedication to creating a robust network of licensees for various applications underscores its commitment to widespread impact. With a focus on promoting 'Natural Nutrient Cycling' through an all-natural, sustainable complex of over 100 compounds, Beem Biologics is well-positioned to drive sustainable growth and enhance yields while simplifying the lives of farmers, golf course managers, and homeowners. This innovative approach aligns with the growing demand for environmentally friendly agricultural solutions, making Beem Biologics a compelling investment opportunity within the manufacturing sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $494.19K | - | 15 Jul 2015 | |
Pre Seed Round | $75.00K | - | 01 Jul 2015 |
No recent news or press coverage available for Beem Biologics, Inc..